首页> 外国专利> METHODS OF MAKING NANOCRYSTALS WITH ENHANCED BIOLOGICAL AVAILABILITY AND FORMULATION FOR SUCH NANOCRYSTALS PREPARATION FOR USE IN ANTICANCER THERAPY

METHODS OF MAKING NANOCRYSTALS WITH ENHANCED BIOLOGICAL AVAILABILITY AND FORMULATION FOR SUCH NANOCRYSTALS PREPARATION FOR USE IN ANTICANCER THERAPY

机译:纳米生物具有增强的生物利用度和配方的方法,用于制备此类纳米晶用于抗癌治疗

摘要

The method of nanocrystal preparation is based on the procedure of the crystalline nanoparticles preparation in powder form that comprises a) dissolving the protonated nitrogen containing derivatives of camptothecin and curcuminoids in an organic solvent leading to formation of self-assembled ionic complex followed by subsequent addition of nonionogenic injectable surfactant, b) transferring the obtained mixture into aqueous medium under continuous homogenization including mixing, shaking and/or using ultrasound, c) removing the solvent in order to obtain powder form, d) lyophilisation of the product with the previously added cryoprotectant. Composition for nanocrystal preparation through the method according to the invention consists of injectable nonionic surfactant and self-assembled ionic complex that contains curcuminoids and protonated nitrogen containing derivatives of camptothecin and its analogues in the molar ratios in the range between 10:1 and 1:10. Analogues of camptothecin include preferably camptothecin and homocamptothecin. Protonated nitrogen containing camptothecin derivatives preferably have the protonated nitrogen included in their chemical structure through at least one functional group including primary amine, secondary amine, tertiary amine, cyclic amine and/or their combinations. Utilization of nanocrystals prepared for the anticancer injectable drug application consists in the dissolution of 3 wt. % nanocrystals in powder form in the liquid medium based on distilled water with 5 wt. % of glucose.
机译:纳米晶体制备方法基于粉末形式的结晶纳米颗粒制备方法,该方法包括:a)将喜树碱和姜黄素的质子化含氮衍生物溶解在有机溶剂中,导致形成自组装的离子络合物,随后添加非离子型可注射表面活性剂,b)在包括混合,摇动和/或使用超声波的连续均质下将获得的混合物转移到水性介质中,c)除去溶剂以获得粉末形式,d)用先前加入的冷冻保护剂冻干产物。通过根据本发明的方法制备纳米晶体的组合物由可注射的非离子表面活性剂和自组装的离子络合物组成,所述离子络合物包含喜树碱和质子化的喜树碱及其类似物的含氮衍生物,其摩尔比范围为10:1至1:10 。喜树碱的类似物优选包括喜树​​碱和高喜树碱。含有质子化氮的喜树碱衍生物优选具有通过至少一个官能团包括在其化学结构中的质子化氮,所述官能团包括伯胺,仲胺,叔胺,环胺和/或它们的组合。制备用于抗癌注射药物的纳米晶体的用途在于溶解3 wt。在基于5wt。%蒸馏水的液体介质中粉末形式的%纳米晶体。葡萄糖%。

著录项

  • 公开/公告号WO2020088702A1

    专利类型

  • 公开/公告日2020-05-07

    原文格式PDF

  • 申请/专利权人 TOMAS BATA UNIVERSITY IN ZLIN;

    申请/专利号WO2019CZ50048

  • 发明设计人 XIAO HAIJUN;SEDLARIK VLADIMIR;

    申请日2019-10-16

  • 分类号A61K9/14;A61K9/19;A61K31/4745;

  • 国家 WO

  • 入库时间 2022-08-21 11:11:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号